WHO Endorses GLP-1 Drugs for Obesity Treatment Amid Access Concerns
Originally Published 1 month ago — by BBC
The World Health Organization warns that less than 10% of those who could benefit from obesity medications like Wegovy have access to them, citing high costs and supply issues, and calls for increased equitable access globally to combat the rising obesity epidemic projected to affect over two billion people by 2030.